Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
about
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsArene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells.Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors.Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
P2860
Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@ast
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@en
type
label
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@ast
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@en
prefLabel
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@ast
Pharmacokinetics of satraplati ...... ministration for 5 or 14 days.
@en
P2093
P1433
P1476
Pharmacokinetics of satraplati ...... dministration for 5 or 14 days
@en
P2093
Ferdy Lejeune
Jean Bauer
Laurent Arthur Decosterd
Serge Leyvraz
Sylvie Vouillamoz-Lorenz
Thierry Buclin
P304
P407
P577
2003-05-01T00:00:00Z